Petros pharmaceuticals announces $10 million offering

New york, nov. 30, 2021 /prnewswire/ -- petros pharmaceuticals, inc. (nasdaq: ptpi), a leading provider of therapeutics for men's health, today announces that it has entered into definitive agreements with the company's largest investor and other existing investors, for the purchase and sale of 3,333,333 shares of petros pharmaceuticals' common stock, at a purchase price of $3.00 per share. the company will sell 2,153,333 shares in a registered direct offering and the remaining 1,180,000 shares will be sold in a private placement.
PTPI Ratings Summary
PTPI Quant Ranking